pyronaridine has been researched along with rifampin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Aguilar-Pérez, C; Aínsa, JA; Brodin, P; Connell, N; Deboosere, N; Ekins, S; Forbak, M; Franch, C; Freundlich, JS; Frita, R; Godbole, AA; Hoffmann, E; Huszár, S; Jha, RK; Kumar, P; Lane, TR; Maxwell, A; Mikušová, K; Mitchenall, LA; Mori, G; Nagaraja, V; Orena, BS; Pasca, MR; Rodrigues, L; Russo, R; Sabbah, M; Vandeputte, A; Veilleux, C; Zemanová, J | 1 |
2 other study(ies) available for pyronaridine and rifampin
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Topics: Antibiotics, Antitubercular; Antimalarials; Antitubercular Agents; Bacterial Proteins; Binding Sites; DNA-Directed RNA Polymerases; Drug Repositioning; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Naphthyridines; Protein Binding; Protein Conformation; Rifampin; Structure-Activity Relationship; THP-1 Cells | 2018 |